SPARC reports net loss of Rs 36.41 core in Q1

01 Aug 2016 Evaluate

Sun Pharma Advanced Research Company (SPARC) reported results for first quarter ended June 30, 2016.

The company has reported a net loss at Rs 36.41 crore for the quarter ended June 30, 2016 as compared to net loss of Rs 1.65 crore for the same quarter in the previous year. The company’s total income decreased by 43.94% to Rs 24.47 crore for the quarter under review from Rs 43.65 crore for the corresponding quarter of the previous year.

Sun Pharma Advanced Research Company is an international pharmaceutical company engaged in research and development of drugs and delivery systems.

Sun Pharma Adv. Res Share Price

134.45 0.70 (0.52%)
30-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 643.75
Indegene 519.25
CMS Info Systems 339.55
Sagility 52.19
Smartworks Coworking 476.45
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×